| abstract |
The subject of the invention is a pharmaceutical composition comprising as active ingredient an analgesic compound and a compound of xanthine structure, where the ratio of the analgesic and the xanthine derivatives is (1-20):1, advantageously 10:1. As analgesic compound preferably morphine, aminophenazone, analgin, acetyl-salicylic acid, indomethacin, ibuprofen, diclophenac, codeine, more preferably analgin, S(+)ibuprofen, diclophenac, as a compound of xanthine structure 3-methylxanthine, theobromine, or CH-13584((1H-purine-2,6-dion-3,7-dihydro-3-methyl-7/5-methyl-1,2,4-oxadiazole-2-yl/methyl), preferably theobromine is used. The compositions of the invention may contain as further active ingredient a smooth muscle spasmolytic, preferably drotaverine. |